As for Tau, we selected the peptide Tau1 (residues 19–34) which is in the N-terminal end of Tau protein, since phospho-Tyr-hTau located in the N-terminal was reported to accompany AD progression and Tauopathy [22]. This evidence concerns the gene MAPT and Alzheimer disease.